e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Prognostic factors and subtyping of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
I. Neves, S. Guimaraes, C. Souto Moura, F. S. Pires, A. P. Vaz, P. Bastos, H. Queiroga, V. Hespanhol, G. Fernandes (Porto, Portugal)
Source:
Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Session:
Prognostic factors and subtyping of lung cancer
Session type:
Thematic Poster Session
Number:
2917
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Neves, S. Guimaraes, C. Souto Moura, F. S. Pires, A. P. Vaz, P. Bastos, H. Queiroga, V. Hespanhol, G. Fernandes (Porto, Portugal). Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?. Eur Respir J 2013; 42: Suppl. 57, 2917
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
The prognostic value of D-dimer in lung carcinoma
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Algorithm of preoperative N-staging of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Surgical treatment outcomes on early-stages of non-small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Primary pulmonary sarcomatoid carcinoma: A case series
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Safety and efficacy of erlotinib in patients with squamous cell lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
PET-CT predictors of mediastinal dissemination in lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
Significance of age, tumor location and histological subtype in lung cancer with brain metastasis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Diaphragm invasion worsen the prognosis as indicated in the 8th TNM
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
ALK/EML4 translocation in non-squamous NSCLC and their predictors
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Molecular profiling of lung squamous carcinogenesis
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Electrospray-mediated local chemotherapy of lung carcinoma in mice
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Added value of EUS-B to EBUS for lung cancer staging
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept